| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/19/2015 | WO2015022546A1 Inhibitors of plasma kallikrein |
| 02/19/2015 | WO2015022497A1 Adjuvants in anti-cancer chemotherapy |
| 02/19/2015 | WO2015022418A1 Treatment of cognitive impairment with pde4 inhibitor |
| 02/19/2015 | WO2015022417A1 Treatment of cognitive impairment with combination therapy |
| 02/19/2015 | WO2015022407A1 Hemisulfate salt of 5,10-methylene-(6r)-tetrahydrofolic acid |
| 02/19/2015 | WO2015022386A1 Combined pharmaceutical preparation for use in treating neuromuscular disorders |
| 02/19/2015 | WO2015022385A1 Form 2 crystalline polymorph of a salt of n-[1-6-(ethynyl-3-oxo-hexahydro-furo[3,2-b]pyrrole-4-carbonyl)-3-methyl-butyl]-4-[5-fluoro-2-(4-methyl-piperazinyl)thiazol-4-yl]-benzamide useful as cysteine protease inhibitor |
| 02/19/2015 | WO2015022351A1 Medicament comprising a pharmaceutical combination of dolutegravir, emtricitabine and tenofovir |
| 02/19/2015 | WO2015022349A1 Dosage form comprising enzalutamide |
| 02/19/2015 | WO2015022332A1 Pyridinones |
| 02/19/2015 | WO2015022301A1 Novel aza-oxo-indoles for the treatment and prophylaxis of respiratory syncytial virus infection |
| 02/19/2015 | WO2015022263A1 Novel aza-oxo-indoles for the treatment and prophylaxis of respiratory syncytial virus infection |
| 02/19/2015 | WO2015022204A1 Coating composition |
| 02/19/2015 | WO2015022073A1 Annelated pyrroles and their use as crac inhibitors |
| 02/19/2015 | WO2015022038A1 3-substituted cyclopentylamine derivatives |
| 02/19/2015 | WO2015021988A1 Pyrrolo-isoquinoline compounds for treatment of pain associated with interstitial cystitis/bladder pain syndrome |
| 02/19/2015 | WO2015021949A1 A thermodynamically stable solid solution of agomelatine for use in a pharmaceutical formulation |
| 02/19/2015 | WO2015021943A1 Inducing neurogenesis by axin enhancer |
| 02/19/2015 | WO2015021929A1 Combined application of isothiocyanate compound and anti-cancer medicine |
| 02/19/2015 | WO2015021922A1 Ginsenoside rd or enteric formulation thereof and use |
| 02/19/2015 | WO2015021894A1 Novel hydroximic acid derivative and medical application thereof |
| 02/19/2015 | WO2015021741A1 Use of doxycycline |
| 02/19/2015 | WO2015021704A1 Uses of doxycycline for preparing antitumor drugs |
| 02/19/2015 | WO2015021561A1 Compositions and methods for making noscapine and synthesis intermediates thereof |
| 02/19/2015 | WO2015021535A1 Methods and uses of melatonin ligands |
| 02/19/2015 | WO2015021534A1 Compositions and methods for control of marine ectoparasites |
| 02/19/2015 | WO2015021530A1 Antiviral methods and compositions comprising probiotic bacterial molecules |
| 02/19/2015 | WO2015021512A1 Sugar cane derived extracts and methods of treatment |
| 02/19/2015 | WO2015006830A9 A method for organ arrest, protection and preservation and reducing tissue injury |
| 02/19/2015 | WO2015003659A9 Traditional chinese medicine composition, and preparation and application thereof |
| 02/19/2015 | WO2014173941A9 Method for obtaining a stable gel of hyaluronic acid and of a free form of vitamin c and/or a salt thereof |
| 02/19/2015 | WO2014097148A9 Tricyclic compounds for inhibiting the cftr channel |
| 02/19/2015 | WO2006111802A9 Process for the preparation of trivalent iron complexes with mono-, di- and polysaccharide sugars |
| 02/19/2015 | US20150051559 Transdermal patch for treatment of dementia or alzheimer type dementia |
| 02/19/2015 | US20150051558 Composition and method for corneal proliferation |
| 02/19/2015 | US20150051444 Drug delivery system for treating erectile dysfunction |
| 02/19/2015 | US20150051347 Block copolymer having phenylboronic acid group introduced therein, and use thereof |
| 02/19/2015 | US20150051299 Treatment of schizophrenia using beta-caryophyllene and cb2 receptor agonists |
| 02/19/2015 | US20150051298 Methods for producing optimal stable nanoemulsions and formulations obtained therefrom |
| 02/19/2015 | US20150051292 Amantadine compositions and methods of use |
| 02/19/2015 | US20150051290 Kinase inhibitors for the treatment of cancer |
| 02/19/2015 | US20150051289 Liquid formulations of hypoglycaemic sulfonamides |
| 02/19/2015 | US20150051288 Methods and Compositions for Treatment of Autism |
| 02/19/2015 | US20150051287 Compositions and Methods for Treating Chronic Inflammation and Inflammatory Diseases |
| 02/19/2015 | US20150051284 Lipid-Lowering Antidiabetic Agent |
| 02/19/2015 | US20150051283 Composition and method for inhibition of pkng from mycobacterium tuberculosis |
| 02/19/2015 | US20150051282 Methods of treating a cardiovascular disorder and/or joint pain in a subject on glucosamine therapy |
| 02/19/2015 | US20150051281 Compositions and Methods for Treating Chronic Inflammation and Inflammatory Diseases |
| 02/19/2015 | US20150051277 Compounds from Anisomeles Heyneana |
| 02/19/2015 | US20150051274 Supplement composition and method of use |
| 02/19/2015 | US20150051272 Uses of hydroxyl polymethoxylflavones (HPMFs) and derivatives thereof |
| 02/19/2015 | US20150051271 Selective ablation of pain-sensing neurons by administration of a vanilloid receptor agonist |
| 02/19/2015 | US20150051269 Drug Delivery Conjugate Capable of Controlled Release, and Use Thereof |
| 02/19/2015 | US20150051261 Methods of Treating Fatty Liver Disease |
| 02/19/2015 | US20150051258 Novel Solid Forms Of Bendamustine Hydrochloride |
| 02/19/2015 | US20150051254 Treatment of Cognitive Impairment With PDE4 Inhibitor |
| 02/19/2015 | US20150051252 Compounds for use in the treatment of neuroblastoma, ewing's sarcoma or rhabdomyosarcoma |
| 02/19/2015 | US20150051250 Prophylactic agent and/or therapeutic agent for stress urinary incontinence |
| 02/19/2015 | US20150051249 Inhibition of mcl-1 and/or bfl-1/a1 |
| 02/19/2015 | US20150051246 Treatment of Cognitive Impairment with Combination Therapy |
| 02/19/2015 | US20150051244 Antibacterial quinoline derivatives |
| 02/19/2015 | US20150051240 COMPOSITIONS OF BUPRENORPHINE AND μ ANTAGONISTS |
| 02/19/2015 | US20150051239 Arylsulfonyl pyrazoline carboxamidine derivatives as 5-ht6 antagonists |
| 02/19/2015 | US20150051236 Combinations Useful for the Treatment of Chronic Lymphocytic Leukemia |
| 02/19/2015 | US20150051235 Compositions and Methods for Treating Cardiovascular Diseases |
| 02/19/2015 | US20150051234 Therapy for complications of diabetes |
| 02/19/2015 | US20150051232 Use of (rs)-s-cyclopropyl-s-(4--5-(trifluoromethyl)pyrimidin-2-yl]amino}phenyl)sulfoximide for treating specific tumours |
| 02/19/2015 | US20150051230 Methods and Compositions for Inhibition of Polymerase |
| 02/19/2015 | US20150051229 Valomaciclovir polymorphs |
| 02/19/2015 | US20150051223 Method of using diketopiperazines and composition containing them |
| 02/19/2015 | US20150051221 Use of Flibanserin for the Treatment of Post-Menopausal Sexual Desire Disorders |
| 02/19/2015 | US20150051216 Oral spray formulations and methods for administration of sildenafil |
| 02/19/2015 | US20150051212 Compositions And Methods For Inhibiting Drusen |
| 02/19/2015 | US20150051210 Tyrosine Kinase Inhibitor Combinations and their Use |
| 02/19/2015 | US20150051209 Compounds and compositions as inhibitors of mek |
| 02/19/2015 | US20150051207 Use of unsaturated sphingosine compounds as chemotherapeutic agents for the treatment of cancer |
| 02/19/2015 | US20150051203 Triazole derivatives as hsp90 inhibitors |
| 02/19/2015 | US20150051202 Triazolopyrazine derivatives |
| 02/19/2015 | US20150051200 Gum resin as a carrier for topical application of pharmacologically active agents |
| 02/19/2015 | US20150051199 Pharmaceutical compounds |
| 02/19/2015 | US20150051198 Highly Concentrated Stable Meloxicam Solutions for Needleless Injection |
| 02/19/2015 | US20150051192 Blocking of cue-induced drug reinstatement |
| 02/19/2015 | US20150051191 Treatment of alcoholism using ibudilast |
| 02/19/2015 | US20150051189 Indolizine compounds, a process for their preparation and pharmaceutical compositions containing them |
| 02/19/2015 | US20150051184 High-purity large-scale preparation of stannsoporfin |
| 02/19/2015 | US20150051182 Methods and related compositions for reduction of fat and skin tightening |
| 02/19/2015 | US20150051181 Process for producing nanoparticles laden with active ingredient |
| 02/19/2015 | US20150051180 Progesterone Antagonist and Selective Progesterone Modulator in the Treatment of Excessive Uterine Bleeding |
| 02/19/2015 | US20150051179 Novel steroidal cyp17 inhibitors/antiandrogens |
| 02/19/2015 | US20150051178 Estriol therapy for autoimmune and neurodegenerative diseases and disorders |
| 02/19/2015 | US20150051175 Co-Administration of Steroids and Zoledronic Acid to Prevent and Treat Pain |
| 02/19/2015 | US20150051172 Pharmaceutical compositions comprising boronic acid compounds |
| 02/19/2015 | US20150051170 External skin agent comprising modified clay for preventing inflammation |
| 02/19/2015 | US20150051168 Stable liquid pharmaceutical composition containing piroxicam or its pharmaceutically acceptable salt and hyaluronic acid or its pharmaceutically acceptable salt and the manufacturing method thereof |
| 02/19/2015 | US20150051166 Methods of Treating Neurological Diseases |
| 02/19/2015 | US20150051165 Application of depolymerized holothurian gylcosaminoglycans (dhg) in preparation of drug for prevention and treatment of thromboembolic diseases |
| 02/19/2015 | US20150051163 Combination therapy for treating cancer |
| 02/19/2015 | US20150051162 Method for treating localized fat deposits |
| 02/19/2015 | US20150051161 Methods for the Detection of Advanced Glycation Endproducts and Markers for Disease |
| 02/19/2015 | US20150051154 Alkylating agents |